GWW

W.W. Grainger, Inc. 2006 Annual Report (10-K) Summary

Business Context and Reporting Period

Company: W.W. Grainger, Inc.
Reporting Period: Fiscal year ended December 31, 2006
Business Model: Leading broad-line supplier of facilities maintenance and related products in North America. Grainger utilizes a multichannel model (branches, sales reps, catalogs, internet) to serve approximately 1.8 million customers.
Segments: Effective January 1, 2006, the company reorganized its reporting into three segments: Grainger Branch-based (U.S., Mexico, China, Puerto Rico), Acklands-Grainger Branch-based (Canada), and Lab Safety Supply (direct marketer).

Key Financial Metrics

Material Changes vs. Prior Period

• Sales Growth: Net sales increased 6.5% year-over-year, driven by strong performance in commercial, government, and manufacturing sectors. Daily sales rose 6.9% despite one fewer selling day in 2006.
• Margin Expansion: Gross profit margin improved by 0.9 percentage points to 40.0%, attributed to favorable product mix, global sourcing, and the wind-down of low-margin integrated supply contracts.
• Operating Expenses: Increased 8.1%, primarily due to higher payroll and benefits costs driven by the adoption of SFAS No. 123R (share-based compensation) and increased healthcare/profit sharing costs.
• Segment Performance:
  • Grainger Branch-based: Sales up 5.6%; Operating earnings up 13.6%.
  • Acklands-Grainger: Sales up 12.6% (including favorable exchange rates); Operating earnings up 8.8%.
  • Lab Safety: Sales up 8.3% (aided by acquisitions of Rand and Professional Equipment); Operating earnings declined 0.8% due to lower margins and higher acquisition-related costs.
• Accounting Changes: Adoption of SFAS No. 123R reduced 2006 EPS by approximately $0.14. Adoption of SFAS No. 158 resulted in a $36.8 million increase to accrued employment-related benefit costs.

Guidance, Outlook, and Risks

• 2007 Outlook: Management anticipates total capital expenditures of $150 million to $175 million, focusing on market expansion ($50M-$80M), IT ($10M-$15M), and international expansion. The estimated effective tax rate for 2007 is projected at 38.5%.
• Growth Drivers: Continued execution of the multiyear market expansion program and product line expansion (adding ~25,000 products in 2007).
• Risks:
  • Economic Sensitivity: Sales correlate with commercial activity and manufacturing output; a slowdown could negatively impact growth.
  • Competition: Highly fragmented industry with competition from manufacturers, wholesalers, and retail enterprises.
  • Supply Chain: Unexpected product shortages could harm customer relationships.
  • Legal: Ongoing litigation involving asbestos and silica exposure (approx. 3,100 plaintiffs as of Jan 2007), though management does not expect a material adverse effect.

Investor Verification Checklist

• Stock-Based Compensation Impact: Verify the ongoing impact of SFAS No. 123R on operating expenses and future EPS as the company continues to grant equity awards.
• Market Expansion ROI: Monitor the return on the significant capital investment ($63M in 2006) in the market expansion program to ensure it drives projected sales growth.
• Postretirement Liability: Review the funded status of postretirement healthcare plans, noting the $36.8 million liability adjustment from SFAS No. 158 and sensitivity to discount rate changes.
• Asbestos Litigation: Track the number of active plaintiffs and insurance coverage discussions regarding asbestos/silica lawsuits.
• Debt Covenants: Confirm continued compliance with debt covenants, noting the company maintains a strong AA+ rating and minimal long-term debt.